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Summary Cell lines selected (CHRC5) and transfected (LR-73-1A) for multi-drug resistance have total lipid
compositions which are indistinguishable between resistant and parental cells. Lipid composition was
evaluated by 'H NMR and the total fatty acid content by GLC. No change in surface hydrophobicity, as
measured with the fluorescent probe dansyl-PE, was observed as a result of transfection of CHO cells with the
mdrl gene. However, the selected cell line, CHRC5, showed a decreased surface hydrophobicity. This decreased
surface hydrophobicity was indicated by an 8 nm increase in the fluorescence emission of dansyl-PE in the
CHRC5 cell line compared with the AB,. Both resistant cell lines showed an increase in the polarisation of the
fluorescent probe, TMA-DPH in the plasma membranes corresponding to a 14% and a 24% change in
fluorescence polarisation for the selected and transfected cell lines, respectively. This is indicative of reduced
mobility of the acyl chains in the resistant cell lines. Both the CHRC5 and the transfected cell lines showed
almost a 2-fold increase in the initial rate of membrane cycling. The membrane cycling could be inhibited by a
known bilayer stabiliser, the N-carbobenzoxy-D-Phe-L-Phe-Gly. These r'esults indicate that the properties of
the plasma membrane from resistant cells are altered compared with their parental cell line.
It has been well established that several tumour cell lines may
develop resistance to a wide variety of cytotoxic agents (Got-
tesmann & Pastan, 1988). The resistance has been linked to
the amplification and overexpression of the mdr gene family
(Riordan et al., 1985; Choi et al., 1991). The main product of
this overexpression is a large glycoprotein situated in the
plasma membrane which acts as a transmembrane drug efflux
pump (Juliano & Ling, 1976).
The cell membrane has become a major focus in cancer
chemotherapy (Powis et al., 1990). The lipid composition and
physical properties of membranes from parental and drug
resistant cell lines have been compared in several studies.
Much of this work has been recently reviewed (Alon et al.,
1991). There are no gross differences in lipid composition
between these two types of cells (e.g. see Sehested et al.,
1989). However, there are several reports of significant
differences in a number of minor lipid components between
MDR and parental cell lines. For example, resistant P388
cells have a lower phosphatidylserine and slightly higher
cholesterol content than their parental counterpart. It has
been suggested that this change in lipid composition cont-
ributes to drug resistance (Escriba et al., 1990). There is also
a 3.6-fold increase in triacylglycerols and an increase in the
phosphatidylethanolamine to sphingomyelin ratio in the lipid
composition of intact doxorubicin-resistant P388 cells
(Ramu et al., 1984). In addition, there are increased amounts
of l-alkenyl-2-acylphosphatidylcholine and I-alkyl-2-acyl-
phosphatidylethanolamine in a vinblastine-resistant cell line
(Wright et al., 1985). Lipids with small headgroups and
unsaturated acyl chains in pure form will pack into inverted
hexagonal phase cylinders rather than bilayers. Hydrophobic
substances such as triacylglycerols will promote the forma-
tion of the hexagonal phase. Thus, all of the above changes
in lipid composition would lead to a greater tendency of
multidrug resistant membranes to non-bilayer phases. As a
result, the membrane bilayer may have a decreased surface
hydrophobicity (Epand & Leon, 1992). In addition, changes
in the ganglioside composition of certain MDR cells has been
observed (Wheeler et al., 1982; Peterson et al., 1983; Ben-
chekroun et al., 1988). A number of different resistant cell
lines have also been shown to contain higher levels of myris-
tic acid (Wilder et al., 1990).
Some differences in the 'fluidity' of parental vs MDR cell
lines have been observed using fluorescent and spin label
probes but the observed differences are generally small and
are not consistent across different resistant cell lines or with
the use of different measures of 'fluidity' (e.g. see Table V of
Alon et al., 1991). However, a number of membrane proper-
ties have been shown to be markedly different between paren-
tal and MDR cell lines. On a gross morphological level, it
has been found that unlike the parental cell line, a resistant
LoVo cell line was incapable of growing as spheroids
(Soranzo et al., 1989). Ultrastructural examination of the
plasma membrane of CHO and human leukemic resistant
cells indicates a higher density of intramembranous particles
than in sensitive cells (Arsenault et al., 1988).
In addition to ultrastructural changes, and to the changes
mentioned above, other differences in membrane properties
have been noted to accompany the development of MDR.
MDR Friend leukaemic cells have decreased electrophoretic
mobility (Tapiero et al., 1986). Differences in the properties
of the surface membrane of MDR cells was also shown by
the effects of concanavalin A. This lectin caused more agg-
lutination of resistant P388 cells than its parental counterpart
and led to a greater internalisation of fluorescently labelled
lectins (Basrur et al., 1985). The ability of resistant P388 cells
to more rapidly internalise the surface membrane has also
been demonstrated by an electron microscopic examination
of the internalisation of cationised ferritin (Sehested et al.,
1987a). This is due to increased plasma membrane recycling
through endosomes which is blocked by verapamil (Sehested
et al., 1987b). Kessel (1988) has measured similar rates of
uptake of TMA-DPH into a sensitive and a resistant P388
cell line. This assay, however, does not measure membrane
cycling or transbilayer diffusion. The transbilayer diffusion of
amphiphiles in plasma membranes is greater in certain resis-
tant cells (Vrignaud & Robert, 1987; Boscoboinik & Epand,
1989).
Recently the mouse mdrl gene which encodes for the
P-glycoprotein has been transfected into a Chinese hamster
cell line (Gros et al., 1986). This gave us the opportunity to
compare membrane lipid compositions and biophysical pro-
perties between parental cell lines and either cells selected for
drug resistance or cells transfected with the mouse mdrl gene.
This will allow determination of whether overexpression of
the P-glycoprotein is directly correlated with alterations in
membrane physical properties.
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Materials and methods
Materials
Foetal bovine serum, a-minimum essential medium, penicillin
and streptomycin were all obtained from Gibco (Grand
Island, NY). Fatty acid free bovine serum albumin (Fraction
V, 98-98%), doxorubicin hydrochloride (dox), dansyl-
phosphatidylethanolamine (DNS-PE) and tetramethyl-
ammonium-diphenylhexatriene (TMA-DPH) were obtained
from the Sigma Chemical Co. (St Louis, MO).
Pentafluorobenzylbromide (PFBBr) was obtained from
Caledon Labs. (Georgetown, Canada) and XAD-2 resin from
BDH (Toronto, Canada). N-carbobenzoxy-D-Phe-L-Phe-Gly
(ZfFG) was obtained from Institute Armand-Frappier
(Laval, Canada).
Cell culture
A wild type Chinese hamster ovary (CHO) cell line (ABI)
and a line provided to us by Dr Ling, which was selected for
resistance to colchicine (CHRC5) were grown in a-MEM
supplemented with 10% foetal bovine serum. These cells
show about 10-fold resistance to vinblastine. The Chinese
hamster cell line transfected with the mouse mdrl gene (LR-
73-lA) and its parental drug sensitive line (LR-73) were
kindly donated by Dr P. Gros (Department of Biochemistry,
McGill University, Montreal, Canada). The LR-73 and LR-
73-lA cell lines were also grown in a-MEM supplemented
with 10% foetal bovine serum. Dox at a concentration of
100 ng ml-' was added to the LR-73-1A culture medium to
ensure against revertants. These cells are about 4-fold resis-
tant to dox.
DNS-PEfluorescence
Dansyl-PE (0.4 mg) was dissolved in 10 LI ethanol and added
to washed cell monolayers in 3 ml PBS (106 cells per 100 mm
dish). Plates were shaken for 20 min at 25°C and subse-
quently washed four times with ice-cold PBS. Cells were then
scraped into 1.5 ml of PBS and fluorescence intensity
measured in a Perkin-Elmer MPF-44 Fluorescence Spect-
rophotometer. The excitation wavelength was 350 nm and
emission wavelength was measured from 450-550 nm at a
rate of 30 nm min-'. Slit widths were set at 6 nm and sam-
ples were continuously stirred to provide a homogenous
suspension. Fluorescence scans of dansyl-PE were also per-
formed in a series of dioxane/water mixtures of known
dielectric constant.
TMA-DPHpolarisation
Steady-state polarisation of TMA-DPH in whole cells was
carried out according to previously published methods
(Spiegel et al., 1981). Measurements were made following a
10 min incubation (25°C) of 106 cells in PBS containing 1 laM
TMA-DPH. Polarisation was calculated according to the
following equation:
P = (Iw - lvh G)/(Iw + Ivh.G)
where I is the emission intensity through polarisers orientated
vertically (I.) and horizontally (Ivh) to the vertical plane of
polarisation of the exciting light. G is the grating correction
factor described by Ivh/Ihh. The wavelength of exciting light
was 360 nm and the emission wavelength was set at
430 nm.
TMA-DPH internalisation
The procedure used to monitor internalisation of TMA-DPH
was based on published methods (Illinger et al., 1990).
Assays were performed on monolayers in 10 cm dishes (106
cells) and incubation times were 0,5, 10, 20 and 40 min.
Following incubation, cells were washed with 3% fatty-free
BSA in PBS to completely remove probe in the plasma
membrane. Fluorescence intensity was measured with excita-
tion and emission wavelengths set at 360 nm and 430 nm
respectively.
'H NMR analysis ofcell membranes
Washed cell monolayers (3 x 107 cells) were scraped into PBS
and pelleted by centrifugation (200g, 5 min). The pellet was
frozen in liquid nitrogen and thawed in 4 ml
chloroform:methanol (2: 1). The suspension was briefly
sonicated to disperse aggregates of cells and filtered through
Whatman #1 paper. The filtrate was added to 50 mM NaCl
(2 ml), mixed and centrifuged (3000g, 5 min). The
chloroform layer was evaporated and the residue suspended
in 5 ml hexane. Anhydrous sodium sulphate was added to
the hexane; the suspension mixed and centrifuged (3000g,
5 min). Sodium sulphate was removed and hexane
evaporated. The residue was dissolved in 500ytl deuterated
chloroform and stored under argon at - 20C in 5 mm NMR
tubes. The 'H NMR spectra were recorded on a Bruker
AM-500 spectrometer operating at a frequency of
500.13 MHz. Spectral parameters: sweep width 10 ppm,
relaxation delay 3 s, spectral data size 16 K.
Fatty acid analysis
Determination of the total fatty acid composition ofcells was
based on published methods (Rosenfeld et al., 1986). Briefly,
washed cell monolayers (5 x 107 cells) were scraped into PBS
and pelleted by centrifugation (2000g, 5 min). The pellet was
suspended in 4 ml K3PO4(pH12.0) and boiled for 1 h at
100°C. The suspension was cooled and the pH adjusted to 7.4
with 1.0 M HCI. The neutralised suspension was then added
to 300 mg of XAD-2 resin and 150 sLI of 9: 1 trich-
loroethylene:PFBBr. This mixture was shaken for 20 min at
25°C. The resin was separated and washed with distilled
water. The derivitised fatty acids were eluted with 10 ml
hexane. Water was removed with anhydrous sodium sul-
phate. Hexane was evaporated under nitrogen at 50°C and
the residue dissolved in 40091l of toluene containing 1 tLg of
external standard. Analyses were carried out on a Hewlett-
Packard 5790 gas chromatograph with a Grob injector for
splitless injection onto capillary columns and detected with a
frequency pulsed electron capture detector. The capillary col-
umn was 30 m x 0.25 mm ID containing an SP330 phase
(0.2ltm).
Statistical analyses
All statistical analyses on comparisons of sample means were
made using the unpaired Student's t-test. In all cases the 0.05
level was considered statistically significant.
Results
Dansyl-PEfluorescence maximum
The fluorescence emission of dansyl-PE in solution was sen-
sitive to the dielectric constant of its surroundings (Ohki &
Arnold, 1990). The emission peak of dansyl-PE was at a
higher wavelength in the CHRC5 cell line than in its drug
sensitive parental line (Table I). An equivalent change in the
Table I The wavelength at maximal emission intensity of dansyl-
phosphatidylethanolamine incorporated into various cell lines
Cell line
AB] CHRCS LR-73 LR-73-lA
Aem(nm) 509±1 517±1 513±2 514±1
p <0.001 N.S.
Values represent mean (± s.d.) ofat least four experiments. P values
indicate the significance in thedifference inemission maximum between
parental and resitant cell lines, i.e. ABI vs CHRC5 and LR-73 vs
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emission peak for dansyl-PE in solution would suggest an
increase in the surrounding dielectric constant of approxi-
mately 10 units. In contrast, there was no significant change
in the emission peak of dansyl-PE in the transfected cell line
(LR-73-1A) compare to its drug sensitive parental line (Table
I).
Steady-statefluorescence polarisation of TMA-DPH
Steady-state polarisation measurements were performed on
whole cells using the fluorescent probe TMA-DPH. The
polarisation value was 14% higher in the CHRC5 cell line
compared to the parental cell line (Table II). Steady-state
polarisation was also higher in the transfected cell line; how-
ever the magnitude of the change was higher (Table II).
Membrane internalisation
Cells were labelled with the fluorescent probe TMA-DPH
and incubated at 37°C. Following incubation, the cells were
washed with a BSA-PBS solution which removed >95% of
the probe from the plasma membrane. The remaining
fluorescence intensity was a measure of plasma membrane
internalisation. Fluorescence intensities were expressed as a
percentage of total intensity incorporated (i.e. in the absence
of washing).
The rate of internalisation is initially linear with time and
is 58% higher in the CHRC5 cell line compared to its paren-
tal line (Table III). In addition, the mean final extent of
internalisation was 20% higher in the CHRC5 cells. The
transfected cell line (LR-73-1A) also exhibited a greater
initial rate of plasma membrane internalisation than its
parental line; the magnitude of the difference was 108%
(Table III). The mean final extent of internalisation was 51%
higher in the LR-73-IA cell line.
The effect of ZfFG on plasma membrane internalisation
was examined in the LR-73-1A cell line. Prior to incorpora-
tion of TMA-DPH, cell monolayers were incubated with
20 iM ZfFG at 37°C for 10min. ZfFG reduced the mean
initial rate of plasma membrane internalisation by 33%
(Table IV). In addition, the extent of membrane internalisa-
tion was reduced by 21%.
Cellular lipid composition determined by 'H-NMR
A typical 'H-NMR spectrum obtained from a whole cell lipid
extract is shown in Figure 1. Peak assignments were taken
Table II The steady-state polarisation ofthe fluorescent probe TMA-
DPH in various cell lines
Cell line
AB] CHRC5 LR-73 LR-73-JA
Polarisation 0.185 ±0.004 0.211 ±0.007 0.173 ±0.009 0.215 ±0.007
(+14%) (+24%)
P <0.02 <0.01
Values represent mean (±s.d.) of five independent experiments. P
values indicate the significance in the difference in the polarisation
betweenparental andresitantcell lines, i.e. AB 1 vsCHRC5 and LR-73 vs
LR-73-1A.
Table III The rate and extent ofTMA-DPH internalisation in various
cell lines
Cell line Rate ofinternalisation Extent ofinternalisation
(% minj') (%)
ABI 0.67±0.02 30.9± 1.9
CHRC5 1.06±0.05 37.1± 1.1
P <0.001 <0.01
LR-73 0.50±0.02 15.7± 1.3
LR-73-1A 1.04±0.07 23.7± 2.5
P <0.001 <0.01
Values are mean (±s.d.) of five independent experiments.
Table IV The effect of 20gim ZfFG on the rate and extent of
TMA-DPH internalisation in drug-resistant LR-73-IA cells
Concentration of Rate ofinternalisation Extent ofinternalisation
ZfFG (% min-') (%)
0 0.91±0.07 19.7± 1.0
20gM 0.61±0.07 15.6± 1.1
P <0.01 <0.02
Values represent the mean (± SD) offive independent experiments.
c
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Figure 1 Typical 500 MHz 'H-NMR spectra of whole cell
(CHRC5) extract. Peak assignment as follows: a, plasmalogen, b,
sphingolipids, c, oleifinic (unsaturated lipids and cholesterol), d,
glycerolipids, e, cholesterol esters, f, cholesterol, g, phosphatidyl-
cholines, h, phosphatidylethanolamines, i, A5 unsaturated lipids, j,
glycerol-fatty acid esters, k, methylene groups of acyl chains and
1, terminal methyl group of cholesterol.
from published methods (Sze & Jardetzky, 1990). The
relative amounts of total cholesterol esters, total phos-
pholipid, phosphatidylcholine, phosphatidylethanolamine, A5
fatty acids, plasmolagens and sphingolipids were determined
by integration of resonances unique to these lipid species.
Phospholipid species such as phosphatidylinositol and phos-
phatidylserine were difficult to resolve but their intensities
indicate they are minor components in each cell line.
31P NMR spectra obtained from the above samples had a
low signal-to-noise ratio and did not indicate the presence of
phospholipids other than PE and PC (data not shown).
The CHRC5 and LR-73-1A cell line did not differ from
their parental lines with respect to composition of several
lipid species (Table V). The PC:cholesterol ratio was approx-
imately 1.0 in each cell line and the PC:PE ratio did not
differ between the CHRC5 and AB1 cells. The latter ratio was
higher in the LR-73-1A cells but this difference was not
statistically significant. The double bond index, a measure of
unsaturation per phospholipid, was also invariant between
the cell lines. This ratio suggests that approximately 58-68%
of the fatty acid species were unsaturated. The amount of
polyunsaturated lipids (i.e. the A5 fatty acids) was also
similar in each cell line.
Cellular composition offatty acids
A typical gas chromatogram of pentafluorobenzyl esters of
fatty acids obtained from whole cell extracts is shown in784 R. CALLAGHAN et al.
Table V The major lipid composition ofwhole cell extracts ofvarious
cell lines
AB] CHRcS LR-73 LR-73-JA
TL 46.5±5.8 49.1± 3.8 52.4± 3.5 50.4±2.7
PC 28.9± 1.7 25.9± 1.4 33.2± 1.7 30.5± 1.4
PE 13.6±1.8 12.5±1.3 14.1±1.7 11.5±2.1
OL 7.5± 1.0 10.6±3.7 7.3± 2.7 8.5± 3.2
ChL 26.8± 3.0 27.3±2.8 30.1 ±4.7 27.9± 1.6
ChL-E 13.7± 1.7 14.6± 1.4 7.1±4.7 10.0± 3.1
PLN 3.7± 1.0 3.3±0.7 4.1± 1.1 4.9± 1.4
SPH 5.9± 1.2 5.8± 1.6 7.6± 2.2 8.0± 3.1
PC/ChL 1.11±0.17 0.96±0.13 1.11±0.15 1.09±0.07
PC/PE 2.12±0.18 2.08±0.12 2.39±0.23 2.72±0.48
DBI 1.23±0.09 1.16±0.10 1.35±0.17 1.34±0.32
A5 index 0.50±0.05 0.49±0.05 0.69±0.03 0.59±0.16
Proportion of each lipid species is expressed as a percentage of the
total lipid determined. Values represent the mean (±s.d.) of five
independent experiments. TL, total phospholipid (including di- and
tri-glycerides); PC, phosphatidylcholine; PE, phosphatidylethanol-
amine; OL, other phospholipids; ChL, cholesterol; ChL-E, cholesterol-
ester; PLN, plasmalogen; SPH, sphingolipids; DBI, double bond index.
DBI and A5 represent the amount ofdouble bounds and A5 groups per
acyl chain.
Figure 2. The major fatty acid species were identified from
retention times of appropriate standards.
The relative amounts of the major fatty acid species (exp-
ressed as % of total fatty acid) did not differ significantly
between the cell lines investigated (Table VI). The percentage
of unsaturated fatty acids was between 68-71%, which con-
curs with data estimated by 'H-NMR. Polyunsaturated fatty
acids comprised 26-31% of all fatty acids.
Discussion
In this study the membrane biophysical properties of multi-
drug resistant cells were characterised. Drug resistant CHRC5










Figure 2 Typical chromatogram of pentafluorobenzylesters of
fatty acids obtained from whole cell (ABI) extracts (lower panel).
A blank chromatogram is shown in the upper panel. Peak assign-
ments as follows: a, C14:0, b, C16:0, C, C16:1, d, C16:2, e, C18:0, f, C18:1,
g, C18:2, h, C18:3, i, C20:4, j, C22:2 and k, C226.
Table VI The majority fatty acid species detected in various cell
lines
Cell line AB] CHRCS LR-73 LR-73-JA
14:0 3.1±0.8 2.8± 1.3 2.3±0.7 2.3±0.1
16:0 17.1±2.4 18.7±2.5 17.6± 1.6 19.2± 1.9
16:1 3.9±2.4 3.7± 1.7 2.4±0.4 2.7±1.5
16:2 7.1±1.6 6.8±3.3 5.8±0.3 5.1±1.1
18:0 9.0±2.1 7.5± 1.3 7.4±0.9 10.0±2.6
18:1 29.1±3.4 30.6±0.9 33.3±2.2 31.1 ±2.5
18:2 5.9± 1.1 6.5±0.9 7.4±0.9 7.4± 1.6
18:3 5.2± 1.6 4.0±2.0 5.0±0.4 7.0±3.4
20:4 5.8±0.9 6.2±0.2 6.0±2.8 6.7±0.4
22:2 1.7±0.4 1.5±0.3 1.3±0.6 1.0±0.1
22:6 2.8±0.5 2.7±0.2 3.3±0.1 3.1±0.7
Others 9.8±3.7 5.7±2.2 7.8±4.4 3.1±1.2
Proportions ofeach fatty acid expressed as a percentage ofthe total
fatty acid determined. Values represent the mean (±s.d.) of four
independent experiments.
pholipid or fatty acid composition. This makes less likely
that there are differences in the lipids of the plasma memb-
rane, but it does not eliminate this possibility. The physical
properties of the plasma membranes of the resistant cells
were however clearly different. The resistant CHRC5 cells had
a decreased surface hydrophobicity and fluidity and the cycl-
ing of their plasma membrane was higher. The CHRC5 cells
acquired resistance by clonal selection after long term
exposure to the cytotoxic cholcicine (Ling & Thompson,
1974). Multiple members of the mdr gene family are exp-
ressed in clonally-selected multi-drug resistant cell lines (Gros
et al., 1991). Any or all of the mdr gene products may be
directly or indirectly responsible for the alterations in the
physical properties of the cell membrane, or the membrane
changes may result from changes in the expression of other
genes and hence may be specific for this particular clonally
selected resistant cell line.
Cells transfected with the mdr genes are less likely to have
incurred changes in the expression of other genes. Recently,
it was shown that retroviral transfer of the human mdrl gene
conferred a level of resistance in newly isolated cells which
was proportional to P-glycoprotein density in the plasma
membrane (Choi et al., 1991). After culturing the transfected
cells for 4 weeks, the level of resistance was still proportional
to P-glycoprotein density, however the proportionality con-
stant was different from that of the newly isolated cells. Thus
for a particular cell condition, resistance is related to P-
glycoprotein expression, but when comparing cells in
different states it was shown that the level of resistance
cannot be predicted solely on the basis of P-glycoprotein.
In this study we have examined membrane properties in a
cell line transfected with the mdrl gene (Schurr et al., 1989)
in which only the expression of this gene is increased. This
cell line overexpresses the P-glycoprotein (Schurr et al.,
1989). No change in total lipid or fatty acid composition of
this transfected cell line was observed in the present study.
However, the polarisation of TMA-DPH fluorescence was
increased. This indicates a decreased mobility of the acyl
chains of membrane phospholipids and is similar to the
change observed with the clonally selected CHRC5 cell line.
Thus, this change in membrane physical property appears
closely associated with MDR although such changes in
'fluidity' are not observed in all MDR cell lines (Alton et al.,
1991).
The absence of any difference in lipid composition suggests
that differences in the physical properties between parental
and MDR cell lines arises from plasma membrane proteins
such as the overexpression of the P-glycoprotein. However,
this does not completely eliminate the possibility that the
lipid environment may be different between the cell lines
since the distribution of the fatty acid chains on the glycerol
backbone of the lipid and the distribution among the lipid
types was not determined nor was the subcellular distribution
of lipid determined.
Unlike the CHRC5 cell line, the transfected cells did not
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exhibit altered surface hydrophobicity. Selection for MDR
results in amplification of several genes. Consequently, pro-
teins other than P-glycoprotein are overexpressed (Meyers &
Biedler, 1991). Some of these proteins, such as the EGF
receptor, are localised in the plasma membrane. Insertion of
any of these proteins or greater surface density of the P-
glycoprotein may be responsible for the decrease in surface
hydrophobicity of the CH5C5 cell line.
The rate and extent of membrane cycling was also in-
creased in both the clonally selected and the transfected
MDR cells. Increased membrane traffic has been implicated
as a mechanism of the resistance phenomenon (Beck, 1987).
It has been proposed that cytotoxic agents may be concent-
rated in cytoplasmic vacuoles which subsequently fuse to the
plasma membrane and extrude their contents. Membrane
cycling is controlled by a wide variety of factor including
membrane composition and protein-lipid interactions (Stein-
man et al., 1983). We propose that the resistant cells have a
less stable membrane (Boscoboinik & Epand, 1989) which
results in increased membrane cycling. This is supported by
the inhibition of membrane cycling by N-carbobenzoxy-D-
Phe-L-Phe-Gly(ZfFG). ZfFG is a membrane stabilising pep-
tide and has been shown to alter other membrane function
such as cell fusion with viruses (Kelsey et at., 1990), the
non-bilayer phase transition temperature (Epand, 1986) and
fusion of model membranes (Epand et al., 1987).
In summary, this study has provided evidence of altera-
tions in the membrane properties of drug-resistant cells.
Some of these properties, such as the fluorescence polarisa-
tion of TMA-DPH and membrane cycling, are altered in
both the selected CHRC5 and the transfected cell lines.
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